Clinical Trial

ESD for Colorectal LSL Using a Selective Strategy - a Prospective Cohort Study

Study acronym: COVERT
Recruiting
View on ClinicalTrials.gov →
Summary
Colonic Laterally spreading lesions (LSL) =\> 20mm are at high risk to progress to cancer. Overt stigmata of submucosal invasive cancer (SMIC) has been well characterized and includes ulceration and surface pit pattern changes as per the Kudo classification of type V. In a recent report, risk factors for LSL with SMIC and no overt stigmata (i.e. covert SMIC) were described. Resection of these lesions 'en-bloc' can allow for better histological staging and potentially reduce the need for surgical resection.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-07-03; most recent amendment 2025-03-25.
Trial Details
NCT Number NCT04008407
Lead Sponsor Western Sydney Local Health District
Conditions Colorectal Neoplasm, Endoscopic Mucosal Resection
Enrollment 391 participants
Start Date 2017-08-14
Primary Completion 2027-08 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2025-03-27